Antiinflammatory cytokines such as interleukin-10 (IL-10) have been used to modulate and terminate inflammation and provide neuroprotection. Recently, we reported that the modular recombinant transfection vector NLSCt is an efficient tool for transgene overexpression in vivo, which induces neuroprotection as a result of its RGD-mediated integrin-interacting capacity. We here sought to evaluate the putative synergic neuroprotective action exerted by IL-10 overexpression using NLSCt as a transfection vector after an excitotoxic injury to the postnatal rat brain. For this purpose, lesion volume, neurodegeneration, astroglial and microglial responses, neutrophil infiltration, and proinflammatory cytokine production were analyzed at several survival times after intracortical NMDA injection in postnatal day 9 rats, followed by injection of NLSCt combined with the IL-10 gene, a control transgene, or saline vehicle solution. Our results show no combined neuroprotective effect between RGD-interacting vectors and IL-10 gene therapy; instead, IL-10 overexpression using NLSCt as transfection vector increased lesion volume and neuronal degeneration at 12 hr and 3 days postlesion. In parallel, NLSCt/IL-10 treated animals displayed increased density of neutrophils and microglia/ macrophages, and a reduced astroglial content of GFAP and vimentin. Moreover, NLSCt/IL-10 treated animals did not show any variation in interleukin-1b or tumor necrosis factor-a expression but a slight increase in interleukin-6 content at 7 days postlesion. In conclusion, overexpression of IL-10 by using NLSCt transfection vector did not synergistically neuroprotect the excitotoxically damaged postnatal rat brain but induced changes in the astroglial and microglial and inflammatory cell response. V V C 2011 Wiley Periodicals, Inc.
Antiinflammatory cytokines such as interleukin-10 (IL-10) have been used to modulate and terminate inflammation and provide neuroprotection. Recently, we reported that the modular recombinant transfection vector NLSCt is an efficient tool for transgene overexpression in vivo, which induces neuroprotection as a result of its RGD-mediated integrin-interacting capacity. We here sought to evaluate the putative synergic neuroprotective action exerted by IL-10 overexpression using NLSCt as a transfection vector after an excitotoxic injury to the postnatal rat brain. For this purpose, lesion volume, neurodegeneration, astroglial and microglial responses, neutrophil infiltration, and proinflammatory cytokine production were analyzed at several survival times after intracortical NMDA injection in postnatal day 9 rats, followed by injection of NLSCt combined with the IL-10 gene, a control transgene, or saline vehicle solution. Our results show no combined neuroprotective effect between RGD-interacting vectors and IL-10 gene therapy; instead, IL-10 overexpression using NLSCt as transfection vector increased lesion volume and neuronal degeneration at 12 hr and 3 days postlesion. In parallel, NLSCt/IL-10 treated animals displayed increased density of neutrophils and microglia/ macrophages, and a reduced astroglial content of GFAP and vimentin. Moreover, NLSCt/IL-10 treated animals did not show any variation in interleukin-1b or tumor necrosis factor-a expression but a slight increase in interleukin-6 content at 7 days postlesion. In conclusion, overexpression of IL-10 by using NLSCt transfection vector did not synergistically neuroprotect the excitotoxically damaged postnatal rat brain but induced changes in the astroglial and microglial and inflammatory cell response. V tory endogenous molecules is upregulated after CNS damage. Accordingly, interleukin-10 (IL-10), a cytokine with a strong antiinflammatory nature (Moore et al., 2001; Strle et al., 2001) , is upregulated in CNS pathologies such as multiple sclerosis (Hulshof et al., 2002) and in different experimental models of CNS injury, including experimental autoimmune encephalomyelitis (EAE; Jander et al., 1998; Ledeboer et al., 2003) , middle cerebral artery occlusion (MCAO; Zhai et al., 1997) , traumatic brain injury (TBI; Kamm et al., 2006) , and a genetic model of Alzheimer's disease (Apelt and Schliebs, 2001) . Notably, as shown after MCAO, expression of proinflammatory molecules decreases when IL-10 is upregulated (Zhai et al., 1997) . In agreement with this, the lack of IL-10 in knockout mice results in an elevated production of proinflammatory cytokines after endotoxic shock (Agnello and Ghezzi, 2000) , and several in vivo and in vitro experimental studies have reported the inhibitory role played by IL-10 administration on inflammatory processes such as astroglial and microglial reactivity (Balasingam et al., 1994; Balasingam and Yong, 1996; Mesples et al., 2003; Jackson et al., 2005; Ooboshi et al., 2005; Pang et al., 2005) ; leukocyte infiltration (Knoblach and Faden, 1998) ; and production of chemokines (Guo et al., 1998) , proinflammatory cytokines Knoblach and Faden, 1998; Sawada et al., 1999; Ledeboer et al., 2000; Molina-Holgado et al., 2001b; Pousset et al., 2001; Ooboshi et al., 2005) , and inflammatory-related enzymes (Molina-Holgado et al., 2001a , 2002a . As a consequence, numerous experimental studies have focused on the neuroprotective potential of IL-10 administration during the course of different CNS pathologies achieving, in many cases, promising results (Knoblach and Faden, 1998; Spera et al., 1998; Brewer et al., 1999; Dietrich et al., 1999; Jackson et al., 2005; Ooboshi et al., 2005) .
However, only a few of the aforementioned studies have looked at the actions exerted by IL-10 in the injured immature CNS. This lack of information becomes especially important when considering that the modulation of the inflammatory response associated with developmental brain damage constitutes a promising therapeutic approach (Hamada et al., 1994; Ferriero et al., 1996; Dammann and Leviton, 1997; Silverstein et al., 1997; Galasso et al., 2000; Tsuji et al., 2000; Acarin et al., 2001; Kadhim et al., 2001; Tahraoui et al., 2001; Arvin et al., 2002; Froen et al., 2002; Mesples et al., 2003; Cai et al., 2004; Cornette, 2004; Leviton and Dammann, 2004; Fan et al., 2005; Chew et al., 2006; Lin et al., 2006; Kremlev et al., 2007; Gonzalez and Ferriero, 2008) and that the immature brain displays distinct physiological and morphological features, as a consequence of its ongoing postnatal development, that determine its particular response to brain damage (Ferriero, 2004; Vannucci and Hagberg, 2004) , including a greater susceptibility to inflammation-mediated damage and exacerbation of the brain's inflammatory response associated with injury (Lawson and Perry, 1995; Dammann and Leviton, 1997; Rezaie and Dean, 2002) . In this regard, we have recently shown that IL-10 and its receptor are upregulated in astroglial and microglial cells in the excitotoxically injured postnatal brain (Gonzalez et al., 2009) and that their increase temporally correlates with a decrease in the expression of proinflammatory molecules such as interleukin-1b (IL-1b), tumor necrosis factor-a (TNFa), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS; Acarin et al., 2002) , strongly supporting the idea that IL-10 overexpression, alone or in combination with other therapies, may constitute an antiinflammatory and putatively protective therapy for immature brain injury.
To modulate postinjury processes, we have demonstrated that the modular protein-based transfection vector NLSCt is an efficient tool for transgene overexpression after developmental excitotoxic damage (Peluffo et al., 2003 (Peluffo et al., , 2006 . Each b-galactosidase subunit of the tetrameric NLSCt accommodates a polylysine tail with DNA-condensing/attaching properties, a nuclear localization motif, and an integrin interacting domain obtained from the GH loop region of the foot-andmouth disease virus, displaying a prototypical threeamino-acid Arg-Gly-Asp (RGD) sequence, showing cell attachment and internalization properties . As we previously shown, intracerebral injection of NLSCt combined with a transgene is able to induce the expression of the carried transgene after excitotoxic injury in neurons, microglia, and astrocytes throughout the damaged tissue for at least 3 days postinjection (Peluffo et al., 2003) . Interestingly, not only is NLSCt effective as a transfection vector for in vivo gene delivery but it also induces neuroprotection mediated by its RGD integrin-interacting capacity (Peluffo et al., 2006 (Peluffo et al., , 2007 . Taking advantage of this special feature of NLSCt, we have reported that the combined use of NLSCt together with the overexpression of transgenic Cu/Zn superoxide dismutase produced an additive response, increasing neuroprotection against excitotoxicity (Peluffo et al., 2005) . The neuroprotective effect of RGD-interaction was dependent on astroglial and microglial cells in vitro and induced an early increase in microglial reactivity (Peluffo et al., 2006 (Peluffo et al., , 2007 , so we hypothesized that the introduction of an astroglial and microglial modulatory gene, such as IL-10, would provide a more effective neuroprotective tool. Therefore, the aim of the present study was to evaluate the putative synergy between the NLSCt-mediated neuroprotection and the potential antiinflammatory and neuroprotective effects of IL-10 overexpression in the excitotoxically damaged postnatal rat brain.
MATERIALS AND METHODS Animals and Excitotoxic Lesions
All experimental animal work was conducted according to Spanish regulations, following European Union directives. The ethical commission of the Autonomous University of Barcelona approved all experimental procedures. All efforts were made to minimize animal suffering at every step.
For this study, we used a total of 115 9-day-old (P9) black-hooded Long Evans rats (15-20 g; Janvier France) of both sexes (litter size was cut to 10 on P0, and, in all cases, litters included similar numbers of males and females). Excitotoxic lesions were performed as previously described (Acarin et al., 1996 (Acarin et al., , 1997 . Briefly, animals were placed in a stereotaxic frame adapted for newborns (Kopf) under isoflurane anesthesia (Veterinaria Esteve, Barcelona, Spain), the skull was opened using a drill, and 0.15 ll of saline solution (0.9% NaCl, pH 7.4) containing 18.5 nmol of N-methyl-D-aspartate (NMDA; Sigma, Steinheim, Germany) was injected into the right sensorimotor cortex at the level of the coronal suture, at 2 mm lateral to bregma and 0.5 mm deep. After suturing, pups were placed on a thermal pad and maintained at normothermia for 1 hr before being returned to the dam.
Treatment Paradigm and Experimental Groups
NLSCt was produced and purified from Escherichia coli as previously detailed . Plasmid DNA containing the IL-10 gene (pORF5/mIL10; Invitrogen, Paisley, United Kingdom) was purified from the DH5a E. coli bacterial strain using a Wizard Plus Minipreps: DNA purification system (Promega, Madison, WI), following the supplier's protocol. Complex formation between transfection vector and plasmidic DNA was induced by coincubation of NLSCt (0.8 lg/ll) with the IL-10 plasmid (0.024 lg/ll) in saline solution at room temperature (RT) for 1 hr before injection.
Two hours after NMDA injection, pups were anesthetized again and injected with 1 ll of NLSCt transfection vector (Peluffo et al., 2006) complexed to the plasmid containing the IL-10 gene, at the same stereotaxic coordinates used for NMDA administration. After suturing, pups were placed again on a thermal pad and maintained at normothermia for 1 hr before being returned to the dam. These animals will be referred to as NMDA/NLSCt/IL-10. In addition, a set of NMDA-lesioned animals was injected with either 1 ll of NLSCt complexed with a plasmid containing the GFP control gene (pEGFP-C1; Clontech, Mountain View, CA) or 1 ll of vehicle saline solution. These animals were used as control groups and will be referred to as NMDA/NLSCt/GFP and NMDA/SAL, respectively.
Experimental Groups and Sample Processing
According to the treatment received and the survival time, animals were distributed in different groups and subgroups as indicated in Table I . For histological and immunohistochemical analysis, rats were intracardially perfused with 4% paraformaldehyde (Sigma) in 0.1 M phosphate buffer. Brains were removed, postfixed for 4 hr in the same fixative, cryoprotected in 30% sucrose, frozen with CO 2 , and stored at -808C. Frozen brains were cut with the aid of a cryostat (Leica Microsystems, Nussloch, Germany), and parallel 30-lm-thick sections were obtained and stored either mounted on gelatin-coated slides or as free-floating sections in Olmos antifreeze buffer at -208C. For protein quantification by ELISAs, pups were sacrificed by decapitation. Ipsilateral brain hemispheres were immediately removed, frozen with liquid nitrogen, and stored at -808C until homogenization in a Potter homogenizer in ice-cold Tris-50 mM/EDTA-1 mM buffer containing a cocktail of protease (Roche, Manheim, Germany) and phosphatase inhibitors (Sigma). Finally, for IL-10 expression analysis by quantitative real-time PCR, pups were killed by decapitation, and ipsilateral brain hemispheres were immediately removed, frozen in liquid nitrogen, and stored at -808C until RNA isolation.
Histology and Immunohistochemistry
Nissl staining. For lesion volume quantification, a set of parallel sections mounted on gelatin-coated slides from each animal was stained by the Nissl method. Briefly, sections were incubated with 0.1% toluidine blue (Panreac, Barcelona, Spain) in Wallpole buffer at room temperature for 5 min and washed with distilled water. Sections were dehydrated, cleared in xylene (Panreac), and coverslipped with DPX (Panreac).
Fluoro-Jade B staining. To visualize degenerating neurons, sections were processed for Fluoro-Jade B (FJB) labeling. Briefly, after hydration in decreasing graded ethanol, sections were rinsed in water and oxidized with 0.06% potassium permanganate (MnO 4 K; Panreac) for 15 min. Then, sections were rinsed in distilled water and immersed for 20 min in 0.0004% FJB (Histo-Chem Inc, Jefferson, AK) plus 1% glacial acetic acid (Panreac) solution. Finally, sections were air dried, dehydrated, and coverslipped with DPX (Panreac). Tomato lectin histochemistry. To visualize microglia/macrophages, sections were processed for tomato lectin histochemistry (Acarin et al., 1994) . Briefly, endogenous peroxidase was blocked by incubating slides for 10 min in 2% H 2 O 2 (Sigma) diluted in 70% methanol (VWR Prolabo, Briare, France) solution. Sections were then rinsed and incubated for 2 hr at 378C in the biotinylated tomato lectin (TL; Lycopersicon esculentum; Sigma) at a 1:150 dilution. After washes, sections were incubated for 1 hr at RT with horseradish peroxidase (HRP)-linked avidin (Dako, Glostrup, Denmark) diluted to 1:200. The peroxidase reaction product was visualized by incubating sections in 100 ml of Tris buffer containing 50 mg 3-diaminobenzidine (DAB; Sigma) and 33 ll H 2 O 2 (Sigma). Finally, sections were dehydrated, cleared in xylene (Panreac), and coverslipped with DPX (Panreac).
Glial fibrillary acidic protein, vimentin, and myeloperoxidase immunohistochemistry. To visualize astrocytes, glial fibrillary acidic protein (GFAP) and vimentin immunohistochemistry were performed, whereas myeloperoxidase (MPO) immunohistochemistry was carried out for neutrophil demonstration. Briefly, three sets of parallel sections mounted on gelatin-coated slides from each animal were processed for endogenous peroxidase blockade as detailed in the previous paragraph. Subsequently, sections were treated with buffer blocking (BB) containing 10% fetal calf serum (FCS; Invitrogen, Paisley, United Kingdom) in Tris-buffered saline (pH 7.4) with 1% Triton X-100 (Sigma) for 1 hr. Then, sections were incubated overnight at 48C plus 1 hr at RT in one of the following primary antibodies: rabbit anti-GFAP (Dako), mouse antivimentin (Dako), and rabbit anti-MPO (Dako) diluted to 1:500, 1:1,000, and 1:400 in BB, respectively. After washes, sections were incubated for 1 hr in either HRP-linked anti-rabbit (GE Healthcare, Buckinghamshire, United Kingdom) or HRP-linked anti-mouse (GE Healthcare) secondary antibodies diluted 1:200. The peroxidase reaction product was visualized using the DAB method as detailed above for TL histochemistry. Finally, sections were dehydrated, cleared in xylene (Panreac), and coverslipped with DPX (Panreac).
CD11b/phosphohistone H3 double immunohistochemistry. To evaluate microglia/macrophage proliferation, double immunofluorescence was carried out, in a set of freefloating sections from a representative animal per experimental group and survival time, by combining CD11b (microglia/macrophage marker) and phosphohistone H3 (p-H3; cell division marker). To accomplish this, sections were first incubated with mouse anti-CD11b primary antibody (Serotec, Oxford, United Kingdom; 1:1,000) and subsequently with Cy2-conjugated anti-mouse secondary antibody (GE Healthcare; 1:1,000). Samples were further processed by using rabbit anti-p-H3 primary antibody (Upstate, Temecula, CA; 1:3,000), followed by incubation with Cy3-conjugated anti-rabbit (GE Healthcare; 1:1,000). Finally, sections were dehydrated, cleared in xylene (Panreac), and coverslipped with DPX (Panreac).
Cytokine ELISAs
IL-1b, TNFa, and IL-6 protein concentrations were evaluated in ipsilateral damaged hemispheres by using the following commercially available kits: IL-1b rat ELISA system, TNFa Rat Biotrak ELISA system, and IL-6 rat ELISA system, according to the manufacturer's instructions (GE Healthcare). Total protein concentration of each sample was obtained by using the bicincholinic acid method (Smith et al., 1985) .
RNA Isolation, cDNA Synthesis, and Real-Time PCR RNA was isolated from frozen ipsilateral damaged brain hemispheres by using the Total RNA Isolation System Kit (Promega). Concentration and purity of mRNA were determined by measuring absorbance at 260 and 280 nm and by electrophoresis. Moreover, to eliminate putative genomic DNA traces, further digestion with turbo-DNase (Applied Biosystems, Foster City, CA) was performed, following the supplier's protocol. DNA digestion was carried out at 378C for 45 min, followed by enzyme deactivation at 708C for 15 min.
Two micrograms of mRNA was retrotranscribed, as described by the provider, by using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) with random hexamers (Applied Biosystems) for transgenic IL-10 and with specific oligonucleotide primers for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH ; Table II) . Retrotranscription was performed at 428C for 45 min, followed by deactivation of the enzyme at 958C for 5 min and 48C for 5 min.
To perform GAPDH quantitative real-time PCR, the SYBR Green PCR Core Reagents Kit was used (Applied Biosystems). Amplification of cDNA was carried out in MicroAmp Optical 384-wells Reaction Plates (Applied Biosystems) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). The reaction mixture (10 ll) was composed of SYBR Green buffer, 3 mM of MgCl 2 , 875 lM of dNTPs with dUTP, 0.3 U of AmpliTaq Gold, 0.12 U of Amperase UNG, 7.5 pmol of each primer (Table II) , 12.5 ng of cDNA and nuclease-free H 2 O. The reaction conditions for cDNA amplification were 2 min at 508C and 10 min at 958C, followed by 40 cycles of 15 sec at 958C and 1 min at 598C. To carry out IL-10 real-time PCR, we used the specific TaqMan Gene Expression Assay (Applied Biosystems) for murine IL-10, following the supplier's instructions. Amplification of cDNA was performed in MicroAmp Optical 96-wells Reaction Plates (Applied Biosystems) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). In this case, cDNA was preamplified by an initial 10 min at 958C, followed by 15 cycles of 15 sec at 958C and 1 min at 608C. Finally, the amplification reaction was performed with an initial 10 min at 958C, followed by 40 cycles of 15 sec at 958C and 1 min at 608C. IL-10 mRNA expression was quantified with reference to the housekeeping gene GAPDH as 2 (threshold cycle of target mRNA -threshold cycle of GAPDH mRNA) . Lesion Volume, Densitometric Analysis, and Cell Counting For lesion volume quantification, 22 parallel Nisslstained sections (from bregma -1.8 mm to bregma 14.5 mm), separated by 300 lm and containing the whole lesion volume, were analyzed for each animal as previously described (Peluffo et al., 2006) . In each section, lesioned area and total ipsilateral hemispheric area were measured by using AnalySIS 3.2 software (Soft Imaging System, Münster, Germany).
As NLSCt-induced transgene overexpression after postnatal excitotoxic injury is restricted to the lesioned nervous parenchyma (Peluffo et al., 2003) , all densitometric and cell count analyses were specifically performed in the lesioned areas. For densitometric analysis, three sections from each animal corresponding to -0.3, 0, and 10.3 mm from bregma were selected, and 320 images were taken at the center of the lesioned ipsilateral hemisphere as well as the corresponding contralateral nonlesioned area (Fig. 1 ). Images were analyzed in AnalySIS 3.2 software (Soft Imaging System). The immunoreactivity grade was calculated as previously described (Acarin et al., 1997 (Acarin et al., , 1999b for GFAP, vimentin, and TL. In all cases, for each animal, values were obtained as the mean of three sections.
Quantification of microglia/macrophages and neutrophil density was performed with the same 320 micrographs (area 5 0.18 mm 2 ) used for densitometric analysis (Fig. 1) . To estimate the density of degenerating neurons, a set of two images/section (340, area 5 0.04 mm 2 ) from the damaged tissue surrounding the central lesion core and from the same sections detailed above were used (Fig. 1) . Images used for cell density evaluation were processed by using the tools for cell counting in AnalySIS 3.2 (Soft Imaging System). Briefly, threshold was set qualitatively according to the immunohistochemical signal in contralateral control hemisphere, and it was maintained unchanged for all images. Subsequently, images were binarized and processed by the application of a particle separation filter. Finally, numbers of particles were measured in each image by using the Analyze particles tool.
Statistical Analysis
In all cases, statistical analysis was performed in Statview 5.0.1 software, and differences among groups were evaluated by means of one-way ANOVA, followed by Fisher's post hoc test. All parameters are presented as mean values 6 SEM, and P < 0.05 was considered statistically significant.
RESULTS
NMDA injection into the sensorimotor cortex of the P9 immature rat brain, as observed in the NMDA/SAL control group, induced tissue damage, neuronal degeneration, and astroglial and microglial responses affecting the ipsilateral sensorimotor cortex, corpus callosum, striatum, and hippocampus, as we have previously described in detail (Acarin et al., 1999a,b) . However, differences in lesion volume, neuronal death, astroglial and microglial reactivity, neutrophil infiltration, and proinflammatory cytokine expression were observed in NMDA/NLSCt/IL-10 and NMDA/NLSCt/GFP animals compared with the NMDA/ SAL control group. Intracortical NMDA injection induced a significant increase in IL-10 gene expression at 72 hpl when lesioned animals were compared with nonlesioned controls. However, no differences were found at earlier or later survival times (10, 24, and 48 hpl and 7 dpl), as we have previously reported in detail (Gonzalez et al., 2009) . In the present study, we sought to evaluate whether NLSCt carrying the IL-10 containing plasmid was able to increase IL-10 expression after the lesion. Quantification of IL-10 expression by real-time PCR showed that, at 24 hpl, NMDA/NLSCt/IL-10 animals displayed a significant increase in IL-10 mRNA content compared with both NMDA/NLSCt/GFP and NMDA/ SAL groups (Fig. 2) .
Lesion Volume and Neuronal Cell Death
Evaluation of injured tissue volume on Nisslstained sections (Fig. 3) showed that, at 12 hpl (Fig. 3) , NMDA/NLSCt/IL-10 animals displayed a significantly higher lesion volume than control NMDA/SAL and NMDA/NLSCt/GFP groups, but no differences were observed between NMDA/SAL and NMDA/NLSCt/ GFP groups. By 72 hpl (Fig. 3) , NMDA/NLSCt/GFP animals exhibited a significant reduction in lesion size compared with the NMDA/SAL control group. Notably, at this time point, NMDA/NLSCt/IL-10 animals did not show significant differences compared with NMDA/SAL control animals but displayed a significant higher lesion volume than the NMDA/NLSCt/GFP group. At 7 dpl (Fig. 3) , no differences in lesion size were detected among the three experimental groups, although a trend toward higher lesion volume wass seen in animals that overexpressed IL-10 (NMDA/NLSCt/ IL-10 vs. NMDA/SAL, P 5 0.09; NMDA/NLSCt/IL-10 vs. NMDA/NLSCt/GFP, P 5 0.06).
Microscopic analysis of FJB staining revealed that neuronal degeneration was more pronounced in NMDA/NLSCt/IL-10 animals than in either the NMDA/NLSCt/GFP or the NMDA/SAL control groups (Fig. 4) . These qualitative observations were confirmed by cell counting, which demonstrated that the density of FJB 1 degenerating neurons at 12 hpl was significantly higher in the NMDA/NLSCt/IL-10 group than in the other two groups (Fig. 4A-D) . By 72 hpl, NMDA/NLSCt/GFP-treated animals displayed an evident reduction in the density of FJB 1 degenerating neurons in comparison with the NMDA/SAL control group, whereas NMDA/NLSCt/IL-10 animals did not differ from the NMDA/SAL controls, showing a significantly higher density of FJB 1 degenerating neurons than NMDA/NLSCt/GFP animals ( Fig. 4A,E-G) . Finally, at 7 dpl, no differences among the three groups were observed (Fig. 4A ,H-J).
Microglial Response
Analysis of sections processed for tomato lectin (TL) histochemistry to evaluate the microglia/macrophage response (Fig. 5) showed that, at 12 hpl, TL 1 microglia/macrophages already exhibited a round, amoeboid profile in all three experimental groups. In NMDA/ NLSCt/GFP and NMDA/NLSCt/IL-10 groups, an increase in the density of TL 1 microglia/macrophages was seen in the lesioned cortex in comparison with NMDA/SAL control animals ( Fig. 5C-E) . In agreement, densitometric analysis and cell counts showed that, at this time point, NMDA/NLSCt/GFP and NMDA/NLSCt/ IL-10 animals exhibited a significantly higher immunoreactivity grade (Fig. 5A ) and increased density of TL 1 microglia/macrophages (Fig. 5B) . By 72 hpl, both round and poorly ramified microglial cells were observed in all groups, but NMDA/NLSCt/IL-10 animals showed a robust increase in the immunoreactivity grade and in the density of TL 1 microglia/macrophages compared with both control groups, which were not different from each other (Fig. 5A,B,F-H) . At 7 dpl, all groups displayed TL 1 cells, mostly poorly ramified (Fig. 5I-K) , and no significant differences between groups were detected by densitometric or cell count analysis. Finally, for all groups, and as shown by double immunofluorescence, we found that only a low percentage of CD11b 1 microglia/macrophages was labeled with the proliferation marker pH3 at the different survival times (Fig. 6 ).
Astroglial Response
Analysis of the astroglial response by GFAP and vimentin immunohistochemistry (Figs. 7, 8) showed no signs of astroglial reactivity in lesioned areas by 12 hpl in any of the three experimental groups. However, by 72 hpl, all groups exhibited a significant increase in the immunoreactivity grade compared with the previous survival time (Fig. 7A,B) . As previously reported (Acarin et al., 1999b) , astroglial reactivity was restricted to the areas of tissue damage and characterized by an increase in the thickness and length of astroglial processes. Notably, at 72 hpl, NMDA/NLSCt/GFP treatment did not induce variations in astroglial reactivity in comparison with the NMDA/SAL control group, and, in NMDA/ NLSCt/IL-10 animals, GFAP and vimentin immunoreactivity was significantly lower than that observed in control groups (Figs. 7A,B, 8A -C,G-I). By 7 dpl, all groups displayed, throughout the whole lesioned parenchyma, maximal astroglial reactivity characterized by an evident increase in the presence of reactive astrocytes, which showed thicker and longer processes and an increase in GFAP and vimentin immunoreactivity grades (Fig. 8D-F and J-L, respectively). No differences between groups were found (Fig. 7A,B) .
Neutrophil Recruitment
In all three groups, analysis of MPO immunohistochemistry for the visualization of neutrophils was carried out at 12 hpl, when maximum neutrophil infiltration occurs in this experimental paradigm (L. Acarin, unpublished observations) . Our results demonstrated the presence of small, round MPO 1 cells with highly stained intracellular granules distributed throughout the whole lesioned parenchyma but showing higher concentration in the lesion center. Noticeably, MPO 1 cell density estimation showed that, compared with the NMDA/ NLSCt/GFP and the NMDA/SAL groups, NMDA/ NLSCt/IL-10 animals exhibited a significant increase in the density of MPO 1 cells (Fig. 9 ).
IL-6, IL-1b, and TNFa Expression
Saline injection in control animals did not induce changes in the levels of IL-1b, TNFa, or IL-6 from 2 hpl until 7 dpl (Acarin et al., 2000) . However, in comparison with saline-injected control animals, NMDA injection in the postnatal rat brain increased IL-1b and TNFa between 10 and 24 hpl and IL-6 protein at 7 dpl (Acarin et al., 2000) . In the present study, we sought to determine the existence of potential differences in the expression of proinflammatory cytokines among the three experimental groups used to perform the present study. Quantification of cytokine content by ELISAs in ipsilateral damaged hemispheres showed that all cytokines analyzed were present in all three groups at all survival times (Fig. 10) . IL-1b concentration was maximal at 12 hpl in all groups, when NMDA/NLSCt/GFP and NMDA/NLSCt/IL-10 groups exhibited a significant increase in IL-1b content in comparison with the NMDA/SAL control group. At 72 hpl and 7 dpl, all experimental groups displayed significantly decreased IL-1b content, and no differences between groups were detected. TNFa expression also reached maximal levels at 12 hpl in all experimental groups, but no significant Figure 7 . Note the apparent decrease in GFAP (C) and vimentin (I) immunoreactivity in the NMDA/NLSCt/IL-10 group at 72 hpl in comparison with the NMDA/SAL group (A and G, respectively) and the NMDA/NLSCt/GFP group (B and H, respectively). Both GFAP and vimentin are increased at 7 dpl in all groups. HPL, hours postlesion; DPL, days postlesion. Scale bars 5 20 lm. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] differences among treatment groups were found at any of the evaluated time points. Finally, although no differences between groups were detected in IL-6 concentration at 12 and 72 hpl, at 7 dpl, when maximal IL-6 content is observed in all groups, NMDA/NLSCt/IL-10 animals displayed a slight increase in IL-6 compared with either the NMDA/NLSCt/GFP or the NMDA/ SAL group.
DISCUSSION
Our results show the neuroprotective effect of the NLSCt transfection vector, conjugated with the GFP control transgene, after postnatal excitotoxic injury, as previously demonstrated (Peluffo et al., 2006 (Peluffo et al., , 2007 . This neuroprotective effect is attributed to the RGD integrin-interacting domain of NLSCt (Peluffo et al., 2007) and is accompanied by an early increase in the microglia/macrophage response. In fact, RGD-mediated neuroprotection is mediated by a glia-dependent mechanism, and it is reliant on the presence of glial cells (Peluffo et al., 2007) . In addition, and diverging from our initial hypothesis (Knoblach and Faden, 1998; Spera et al., 1998; Brewer et al., 1999; Dietrich et al., 1999; Froen et al., 2002; Mesples et al., 2003; Rodts-Palenik et al., 2004; Jackson et al., 2005; Ooboshi et al., 2005; Pang et al., 2005) , treatment with NLSCt combined with IL-10 overexpression did not induce further neuroprotection over that observed with the administration of NLSCt carrying the control transgene. On the contrary, at 12 hpl and 3 dpl, a significant increase in lesion volume and neurodegeneration was observed in lesioned animals treated with IL-10.
Dual Effect of IL-10 Overexpression on Lesion Progression in the Immature vs. the Adult Brain
Although it has been widely reported that IL-10 may induce neuroprotection in different models of acute CNS injuries (Knoblach and Faden, 1998; Spera et al., 1998; Brewer et al., 1999; Dietrich et al., 1999; Froen et al., 2002; Mesples et al., 2003; Rodts-Palenik et al., 2004;  Jackson et al., 2005; Ooboshi et al., 2005; Pang et al., 2005) , conflicting results, based on different experimental approaches, have also been reported (Knoblach and Faden, 1998; Brewer et al., 1999; Mesples et al., 2003) . In this sense, systemic administration of IL-10 is neuroprotective in different injury paradigms (Knoblach and Faden, 1998; Brewer et al., 1999; Froen et al., 2002; Mesples et al., 2003; Rodts-Palenik et al., 2004; Pang et al., 2005) , whereas intraparenchymatic administration can be neuroprotective (Spera et al., 1998; Dietrich et al., 1999; Jackson et al., 2005; Ooboshi et al., 2005) , provide no effect in lesion outcome (Knoblach and Faden, 1998; Mesples et al., 2003) , or even be deleterious for lesion progression (Brewer et al., 1999) . Notably, age is a crucial factor determining IL-10-mediated effects after acute CNS injuries, insofar as, in contrast to the adult, the postnatal brain exhibits a deficient response to this antiinflammatory cytokine. In agreement, neither IL-10 gene deletion nor intracerebral IL-10 administration showed an effect on lesion development after neonatal excitotoxicity (Mesples et al., 2003) . Importantly, Mesples and colleagues (2003) have shown that intracerebral IL-10 administration at the time of excitotoxic lesion induction, showed a nonsignificant dose-dependent tendency toward increased lesion size, which was counteracted by anti-IL-10 antibody administration. This attenuated effect could be explained by the fact that IL-10R expression is very low in the excitotoxically lesioned neonatal rat brain until 48 hpl (Gonzalez et al., 2009) . Accordingly, in the present study, in which IL-10 overexpression follows the temporal pattern of IL-10R expression in postnatal excitotoxicity (Gonzalez et al., 2009 ), IL-10 significantly increased lesion volume and neurodegeneration, even in the context of a neuroprotective transfection vector, further demonstrating the differential response of the immature brain to this antiinflammatory cytokine. A similar deleterious effect of antiinflammatory cytokines during immaturity has been reported after transforming growth factor-b (TGF-b) administration, which increases damage severity in a model of postnatal ibotenate-mediated excitotoxicity (Mesples et al., 2005) , whereas it is neuroprotective after adult brain damage (Buisson et al., 2003) . Altogether, these observations support the hypothesis that the injured immature brain responds particularly to antiinflammatory based approaches (Northington, 2006) , highlighting the need to generate specific neuroprotective strategies for the neonatal brain.
In addition to the detrimental effect of IL-10 overexpression in our experimental paradigm, our results also show that IL-10 overexpression, by means of the neuroprotective transfection vector NLSCt, modulates inflammatory processes, increasing leukocyte infiltration and unbalancing the astroglial and microglial responses after postnatal excitotoxicity.
IL-10 Overexpression Increased Neutrophil Infiltration
Correlating with the IL-10-mediated increase in lesion volume and neurodegeneration, we observed, at Graphic representation of interleukin-1b (IL-1b), tumor necrosis factor-a (TNFa), and interleukin-6 (IL-6) concentration in ipsilateral damaged hemispheres at different survival times and experimental groups shows a significant increase in IL-1b in both NMDA/ NLSCt/IL-10 and NMDA/NLSCt/GFP groups at 12 hpl and a mild increase in IL-6 expression in NMDA/NLSCt/IL-10 animals at 7 dpl. Notably, we have previously demonstrated (Acarin et al., 2000) that saline injection into the postnatal rat brain did not modulate the expression of these cytokines and that NMDA injection increased IL1b and TNFa at 10 and 24 hpl and IL-6 protein levels at 7 dpl compared with saline-injected control animals. Statistically significant differences: *compared with NMDA/SAL, & when comparing with the same group at the previous survival time. HPL, hours postlesion; DPL, days postlesion. 12 hpl, an increase in MPO 1 cells in the lesioned tissue with the morphological characteristics of neutrophils, the main cell type expressing the enzyme MPO at this early postlesion survival time after stroke or excitotoxicity (Breckwoldt et al., 2008; Campuzano et al., 2011) . Previous reports have described neutrophil accumulation after acute damage to the postnatal CNS (Lawson and Perry, 1995; Hudome et al., 1997; Palmer et al., 2004) , which are thought to induce injury exacerbation by reducing the microvascular flow and releasing inflammatory and cytotoxic molecules (Kochanek and Hallenbeck, 1992; Hartl et al., 1996; Acarin et al., 2002) . In agreement, experimental interventions aiming to reduce polymorphonuclear cell infiltration induced neuroprotection after acute immature brain injury (Hudome et al., 1997; Palmer et al., 2004) . Notably, NLSCt treatment itself did not change postlesion neutrophil recruitment (Peluffo et al., 2007) , suggesting a role of IL-10. However, although the increase in neutrophil density seems to correlate with the IL-10-induced exacerbation of tissue damage reported here, we do not have any explanation to clarify the IL-10-mediated effect on neutrophil infiltration, because it is established that IL-10 inhibits the production of several CXC chemokines in immune cells (Moore et al., 2001 ) and, specifically, IL-8 production in microglial cultures (Ehrlich et al., 1998) . Moreover, previous reports in the damaged adult brain have demonstrated that IL-10 inhibits neutrophil infiltration (Abraham et al., 2004) , further supporting the idea that age-dependent differences may account for this unexpected effect of IL-10.
IL-10 Overexpression Reduced Astroglial Reactivity
As previously reported with other injury paradigms, IL-10 overexpression reduced astroglial GFAP and vimentin immunoreactivity (Balasingam and Yong, 1996; Pang et al., 2005; Woiciechowsky et al., 2004) . In contrast, NLSCt administration itself did not modulate the astroglial response, suggesting that the reduction in astroglial GFAP and vimentin is mediated by IL-10, probably by a direct mechanism, because we have recently shown that reactive astrocytes are the main cell type expressing IL-10 receptor (IL-10R) in this lesion model (Gonzalez et al., 2009) . Notably, correlation of reduced astrogliosis with damage exacerbation has been previously reported by using genetic ablation of astroglial intermediate filaments, leading to increased brain damage severity (Nawashiro et al., 1998 (Nawashiro et al., , 2000 , and has been related to reduced astroglial capacity to respond to hypoosmotic stress, to regenerate the compromised bloodbrain barrier, or to undergo glutamate uptake (Anderova et al., 2001 ). In the same way, potentially neuroprotective functions of astroglial response include neuronal trophic and metabolic support, oxygen free radicals detoxification, or secretion of factors involved in angiogenesis and revascularization (Liberto et al., 2004) , further supporting the correlation between reduced astroglial reactivity and increased lesion volume and neurodegeneration.
NLSCt Induced Early-Activated Microglia, but IL-10 Overexpression Elicited a Sustained Microglial Activation
The neuroprotective effect of NLSCt treatment was accompanied by an early increase in microglia/macrophage response, but neurotoxicity observed after IL-10 overexpression correlates with a sustained exacerbation of the microglial response until 3 dpl, suggesting that early, but not sustained, microglial activation can be related to neuroprotection. Either an increase in endogenous microglial proliferation or an increased recruitment of peripheral monocytes could be the cause of the IL-10-mediated increase in microglia/macrophages at 3 dpl. In this regard, our colocalization studies between the proliferation marker pH3 and microglial cells showed no apparent differences in pH3 immunostaining between the groups at 12 hpl and 3 dpl, implying that microglia/ macrophage increase could be related to monocyte infiltration. However, although this hypothesis may well correlate with the IL-10-induced rise in neutrophil recruitment reported here, IL-10 is known to inhibit leukocyte infiltration to the damaged adult brain (Kline et al., 2002; Abraham et al., 2004) and to reduce the adhesion capacity of monocytes and lymphocytes to endothelial cells in vitro (Krakauer, 1995; Mostafa Mtairag et al., 2001) , probably by inhibiting adhesion molecules and chemokines (Krakauer, 1995; Buchwald et al., 1999) . In this regard, although IL-10 effects on the microglia/macrophage response may constitute a direct effect of IL-10, as this cell population expresses IL-10R (Gonzalez et al., 2009) ; an indirect effect mediated by the reduction in the astroglial response may also have a prominent role. In this regard, ablation of proliferating reactive astrocytes in different models of acute injury induces an evident increase in the number of infiltrated leukocytes and phagocytic cells (Bush et al., 1999; Faulkner et al., 2004; Myer et al., 2006) .
It should also be mentioned that IL-10 inhibits microglial activation, both in vitro (Shrikant et al., 1995; O'Keefe et al., 1999; Sawada et al., 1999) and in vivo, in both adult and postnatal models of injury (Balasingam and Yong, 1996; Jackson et al., 2005; Ooboshi et al., 2005; Pang et al., 2005) , raising the possibility that the IL-10-mediated effects on microglial response reported here depend on the earlier microglial induction by NLSCt.
NLSCt Induced an Early Increase in IL-1b, but IL-10 Did Not Modulate Proinflammatory Cytokines NLSCt administration, concomitantly with its neuroprotective action, induced an early and transient increase in IL-1b production, correlating with the increase in the density of microglia/macrophages, the main cell type expressing IL-1b (Acarin et al., 2000) . This increase in IL-1b production is somewhat surprising, insofar as IL-1b has been classically considered to be deleterious to lesion outcome, in both the adult brain (Rothwell, 2003) and the postnatal brain (Hagan et al., 1996; Hagberg et al., 1996; Cai et al., 2004) .
Otherwise, the IL-10-mediated modulation of astroglial and microglial cell responses was not associated with overall changes in the production of the main proinflammatory cytokines produced by these glial populations (Acarin et al., 2000) . IL-1b and TNFa were not affected, and only a mild increase in late IL-6 production was seen. However, reports on adult animals and in vitro studies have demonstrated that IL-10 is a strong inhibitor of IL-1b, TNFa, and IL-6 Lodge and Sriram, 1996; Knoblach and Faden, 1998; Pousset et al., 1999; Sawada et al., 1999; Ledeboer et al., 2000; Molina-Holgado et al., 2001b; Ooboshi et al., 2005) , key factors in the initiation and propagation of CNS inflammation (Gadient and Otten, 1997; Shohami et al., 1999; Touzani et al., 1999; Allan and Rothwell, 2001; Rothwell, 2003) . These observations further indicate age-related differences in the astroglial and microglial response to IL-10 and/or in the inhibitory role of IL-10 on proinflammatory cytokine production. The latter is further supported by the fact that peripheral blood monocytes, which constitute microglial precursors (Cuadros and Navascues, 1998; Kaur et al., 2001) , are less responsive to IL-10-mediated inhibition of proinflammatory cytokine production when they are obtained from newborns compared with those isolated from adults (Schultz et al., 2004) .
In conclusion, this study shows that the combined use of IL-10 overexpression together with the RGDinteracting vector NLSCt did not synergistically exert a neuroprotective action; instead, IL-10 overexpression was deleterious for excitotoxic damage progression, including exacerbation of neurodegeneration, neutrophil recruitment, and microglia/macrophage response, which occurred concomitantly with a downregulation of the astroglial response and no overall changes in inflammatory cytokine production.
